Redefining Cure in Clostridium difficile Infection: Clinical Assessment 4 Weeks Aft er Fecal Microbiota Transplantation Is Predictive of Standard 8-week Cure Endpoint

Allegretti Jessica R.; Phelps Emmalee; Xu Huiping; Kassam Zain; Fischer Monika

首页> 外文期刊>The American Journal of Gastroenterology >Redefining Cure in Clostridium difficile Infection: Clinical Assessment 4 Weeks Aft er Fecal Microbiota Transplantation Is Predictive of Standard 8-week Cure Endpoint

【24h】

Redefining Cure in Clostridium difficile Infection: Clinical Assessment 4 Weeks Aft er Fecal Microbiota Transplantation Is Predictive of Standard 8-week Cure Endpoint

机译：重新定义艰难梭菌感染的治疗方法：粪便微生物菌群移植后4周的临床评估可预测标准的8周治疗终点

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The American Journal of Gastroenterology》 |2016年第1期|共1页
作者
Allegretti Jessica R.; Phelps Emmalee; Xu Huiping; Kassam Zain; Fischer Monika;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献

1. Redefining Cure in Clostridium difficile Infection: Clinical Assessment 4 Weeks Aft er Fecal Microbiota Transplantation Is Predictive of Standard 8-week Cure Endpoint [J] . Allegretti Jessica R., Phelps Emmalee, Xu Huiping, The American Journal of Gastroenterology . 2016,第Suppla1期

机译：重新定义艰难梭菌感染的治疗方法：粪便微生物菌群移植后4周的临床评估可预测标准的8周治疗终点
2. IVIG – A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection, which failed standard therapy including fecal microbiota transplants and fidaxomicin [J] . Kelley Coffman, Xian Jie Cindy Chen, Charles Okamura, ID Cases . 2017,第2期

机译：IVIG –可以治愈重度难治性NAP-1 艰难梭菌结肠炎吗？成功治疗严重感染的病例，但未通过标准治疗，包括粪便微生物菌群移植和非达索霉素
3. IVIG – A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection, which failed standard therapy including fecal microbiota transplants and fidaxomicin [J] . Kelley Coffman, Xian Jie Cindy Chen, Charles Okamura, ID Cases . 2017,第1期

机译：IVIG –可以治愈重度难治性NAP-1 艰难梭菌结肠炎吗？成功治疗严重感染的病例，但未通过标准治疗，包括粪便微生物菌群移植和非达索霉素
4. The Efficacy of Fecal Microbiota Transplantation in Elderly Patients with Clostridium Difficile Infection [D] . Lee, Dayeun 2019

机译：粪便微生物群移植在老年腹菌感染患者中的疗效
5. IVIG – A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection which failed standard therapy including fecal microbiota transplants and fidaxomicin [O] . Kelley Coffman, Xian Jie Cindy Chen, Charles Okamura, 2017

机译：IVIG –可以治愈重度难治性NAP-1艰难梭菌结肠炎吗？成功治疗严重感染的病例但标准治疗失败包括粪便菌群移植和非达索霉素
6. IVIG – A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection, which failed standard therapy including fecal microbiota transplants and fidaxomicin [O] . Kelley Coffman, Xian Jie Cindy Chen, Charles Okamura, 2017

机译：IVIG - 治疗严重难治性Nap-1艰难梭菌结肠炎？成功治疗严重感染的病例，其标准治疗失败，包括粪便微生物群移植和fidaxomicin
7. Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium Difficile Infection Not Responsive to Standard Therapies. [R] . 2013

机译：行业指南：关于使用粪便微生物群移植治疗艰难梭菌感染的研究新药要求的执行政策不符合标准疗法。

Redefining Cure in Clostridium difficile Infection: Clinical Assessment 4 Weeks Aft er Fecal Microbiota Transplantation Is Predictive of Standard 8-week Cure Endpoint

著录项

相似文献

相关主题

期刊订阅